Kobayashi Pharmaceutical Co., Ltd. (TYO:4967)

Market Cap	403.51B
Revenue (ttm)	163.18B
Net Income (ttm)	11.53B
Shares Out	74.34M
EPS (ttm)	155.13
PE Ratio	34.99
Forward PE	30.37
Dividend	104.00 (1.92%)
Ex-Dividend Date	Dec 29, 2025

Volume	449,700
Average Volume	280,245
Open	5,382.00
Previous Close	5,463.00
Day's Range	5,373.00 - 5,495.00
52-Week Range	4,850.00 - 6,310.00
Beta	0.27
RSI	62.67
Earnings Date	Feb 10, 2026

About Kobayashi Pharmaceutical

Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan, the United States, and internationally. The company offers Ammeltz, an anti-inflammatory pain relief medicine; Dent, an effervescent denture cleaning agent; Ekitai Bluelet Okudake, a toilet bowl cleaner; Naicitol, a Chinese herbal medicine that promotes the breakdown and metabolism of fat; BreathCare, an oral breath freshener capsule; Netsusama sheet, a cooling g...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 1886
• Employees: 3,615
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4967

Financial Performance

In 2024, Kobayashi Pharmaceutical's revenue was 165.60 billion, a decrease of -4.53% compared to the previous year's 173.46 billion. Earnings were 10.07 billion, a decrease of -50.50%.